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Abstract
Background: Random gene inactivation used to identify cellular functions associated with
virulence and survival of Brucella spp has relied heavily upon the use of the transposon Tn5 that
integrates at G/C base pairs. Transposons of the mariner family do not require species-specific host
factors for efficient transposition, integrate nonspecifically at T/A base pairs, and, at a minimum,
provide an alternative approach for gene discovery. In this study, plasmid vector pSC189,
containing both the hyperactive transposase C9 and transposon terminal inverted repeats flanking
a kanamycin resistance gene, were used to deliver Himar1 transposable element into the B.
melitensis genome. Conjugation was performed efficiently and rapidly in less than one generation in
order to minimize the formation of siblings while assuring the highest level of genome coverage.
Results: Although previously identified groups or classes of genes required for virulence and
survival were represented in the screen, additional novel identifications were revealed and may be
attributable to the difference in insertion sequence biases of the two transposons. Mutants
identified using a fluorescence-based macrophage screen were further evaluated using gentamicin-
based protection assay in macrophages, survival in the mouse splenic clearance model and growth
in vitro to identify mutants with reduced growth rates.
Conclusion: The identification of novel genes within previously described groups was expected,
and nearly two-thirds of the 95 genes had not been previously reported as contributing to survival
and virulence using random Tn5-based mutagenesis. The results of this work provide added insight
with regard to the regulatory elements, nutritional demands and mechanisms required for efficient
intracellular growth and survival of the organism.
Background
Previous studies designed to identify genes related to Bru-
cella virulence and survival utilized Tn5-based mutagene-
sis strategies. Although useful in identifying numerous
factors, this approach may be restricted in potential by the
sequence bias for integration of Tn5 in GC-rich DNA
sequences [1]. In contrast, Himar1 transposable element
has a different target specificity and integrates at TA base
pairs [2]. As a result of these different specificities, the two
transposons are expected to provide complementary tools
for gene discovery related to virulence and intracellular
survival. However, rather than identifying completely new
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within previously described groups would be identified.
Functional characterization and sequence analysis of the
Brucella genome have identified few classically defined
virulence genes. When narrowly defined, virulence factors
are those functions specifically designed to interact with
the host cell, to enhance replication or survival, and have
no effect on the organism when grown under laboratory
conditions. Although this concept is useful when attempt-
ing to restrict the number of mutants and to target func-
tions or mechanisms that are specific for survival of the
organism, it may overlook the significance of gene prod-
ucts that sustain the organism in crucial intracellular envi-
ronments. Brucella virulence results from the ability of the
organism to survive and replicate within the professional
phagocytic cells of the host [3]. Similarities between Bru-
cella and plant pathogens are notable in the conservation
of metabolic functions with the potential to enhance sur-
vival and persistence within different environments [4].
Much has been made of the environment in which Bru-
cella sp. persist and replicate as well as the importance of
several metabolic pathways to survival [5-8]. Perhaps
more importantly, some metabolic pathways could pro-
vide specific targets for the development of new antibiot-
ics capable of restricting intracellular replication.
However, physical characterization of the "brucellasome"
is just beginning [9,10] and it is important to remember
that mutants exhibiting reduced in vivo replication may
reflect minor growth defects that are exacerbated in the
host as a result of exposure to additional stress. As such, it
is difficult to make general predictions concerning nutri-
tional pathways and relative importance to survival and
virulence.
The work reported extends knowledge of pathogenic and
metabolic functions necessary for survival and helps to
improve definition of the replicative niche in which fully
virulent Brucella persist. Intracellular survival in macro-
phage is responsible for virulence in the host, and in the
experiments described, macrophage were used to screen a
bank of mutants for defects in intracellular survival. The
mouse provides a confirmation of virulence potential and
is used here as a model for other animal species. In this
model, the organism replicates and colonizes the spleen
in elevated numbers causing a splenomegaly, but over
time the numbers of organisms decline and splenomegaly
subsides (a property that has not been characterized in
other species including man). The outcome of these
experiments is the identification of a large number of
genes associated with virulence, of which nearly two-
thirds have not been identified using random insertion
mutagenesis.
Results
Construction of the mariner mutant bank
pSC189, containing the Himar1 transposable element in
E. coli β2155, was the kind gift of Eric Rubin (Harvard
School of Public Health). Following conjugation, as
described in Materials and Methods, the viability of Bru-
cella, as determined by the overall number of colony form-
ing units (CFUs) recovered following conjugation, was
shown to decrease 10–20% over the course of the experi-
ment while the number of E. coli β2155 CFUs increased as
much as fourfold. Under these conditions transformation
of Brucella to kanamycin resistance occurred at a fre-
quency of 1 in 100 to 1000 Brucella, and transformants
were isolated by plating on TSA supplemented with kan-
amycin. The generation time was determined to be four
hours under these conditions, and few if any siblings were
expected to be identified. Digestion of genomic DNA with
NcoI to produce two characteristic fragments following
Southern blotting revealed that each of 100 mutants
selected at random had inserted into different regions of
the genome and that selection provided mutants with
unique transposon insertions (data not shown). Sequence
analysis described below is also consistent with a low
number of siblings in the mutant bank.
Identification of mutants with reduced survival relative to 
parental strain in macrophages
To identify mutants with reduced capacity to survive and
replicate intracellularly, all the mutants were analyzed
using the mouse macrophage-like cell line J774.A1 in the
96-well tissue culture plates. In order to minimize the
number of false positives attributable to poor growth of
the inoculum, mutant growth was determined after 48
hours in vitro by optical density readings using a BioRad
microplate reader; mutants exhibiting poor growth in liq-
uid media were eliminated from analysis. Cells were
infected at an approximate multiplicity of infection
(MOI) of 50 in duplicate, and after 48 hours intracellular
bacteria were stained with goat anti-B. melitensis 16 M
antibody and Alexa Fluor 488-conjugated donkey anti-
goat IgG (Molecular Probes, Eugene, Oregon, USA) to
avoid artifacts due to over expression of green fluorescent
protein (GFP) [11]. Following the first round of fluores-
cent microscopic examination, 1,020 mutants (5.5% of
the mutant bank) were identified as attenuated based on
limited intracellular replication or a reduced number of
infected cells (Fig. 1). A second round of fluorescent
microscopic evaluation was performed with the 1,020
mutants to eliminate mutants that were mischaracterized
(i.e., false positives) in the first round of screening. Fol-
lowing this second round of screening, 443 mutants
(2.4% of the mutant bank) were confirmed via fluores-
cence microscopy as attenuated for intracellular growth.Page 2 of 15
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these mutants, replication was monitored relative to the
parental strain B. melitensis 16 M over a 48 hour period in
macrophages using the gentamicin protection assay
described in Materials and Methods. Mutants exhibiting
reduced recovery (tenfold or lower CFU compared to the
parental strain) after 48 hours of growth in macrophage
were selected for DNA sequencing (n = 200). These
mutants were thought to encode critical regulatory func-
tions or pathogenic mechanisms that more drastically
affect survival. The remaining 243 mutants were not char-
acterized in this study. DNA sequencing of the 200
mutants revealed the interruption of only 95 genes (Table
1), and 36 of the 95 genes identified were interrupted in
multiple mutants. However, insertions in only two genes
appeared to have identical transposon interruptions and
to represent potential siblings consistent with earlier
claims of elevated recovery of independent interruptions.
Several publications have reported the identification of
genes involved in virulence and survival of Brucella using
Tn5-based random mutagenesis [6,12-14]. Yet, the use of
the mariner transposon has revealed 57 novel genes inser-
tions out of 95 identified in the studies reported here that
have not been identified in any of those previous studies
(Table 1).
Novel gene interruptions (and some previously character-
ized mutations) were further evaluated using the macro-
phage survival assay and the mouse splenic clearance
model of infection. The results of this analysis are pro-
vided in Table 2. The identified virulence genes/operons
are distributed evenly on the two chromosomes with clus-
tering pronounced in virB, luxR, gltAB and pur loci (Table
2). Functions may be ascribed to 49 of the 57 genes; these
are summarized in Table 2 in which the genes identified
are classified according to Clusters of Orthogonal Groups
(COGs). Seven genes lacked orthologs within microbial
databases, and at least five others require additional char-
acterization to confirm function. In addition, ten of fifty-
seven newly identified interruptions are located within
intergenic regions (indicated by an "/") between previ-
ously untargeted genes and will require additional charac-
terization to confirm which of the flanking genes is
responsible for attenuation of survival.
Confirmation of reduced survival relative to parental 
strain in the mouse splenic clearance model
To confirm the relationship between reduced survival in
macrophages and rapid clearance from the host, a sub-
group of 22 newly identified mutants were evaluated for
survival in the mouse splenic clearance model. The results
confirm the predictions based on reduced survival in mac-
rophages and suggest previously unidentified key roles for
these genes in survival in the animal model (Table 2 and
Fig. 2). In contrast, mutants that exhibited normal intrac-
ellular growth patterns in the fluorescence assay did not
exhibit significant differences in survival in the mouse
model (data not shown). Among the mutants exhibiting
extremely of reduced survival were several with Himar
insertions in important regulatory elements. Although not
a novel identification, interruption of luxR (BME1116)
severely reduced survival, while at least 4 other luxR
orthologs present in the Brucella genome were not
detected in this screen. Additional transcriptional regula-
tory elements that appear to be involved in regulating vir-
ulence in Brucella are virF (BMEI0371), sigma factor; ompR
(BMEI0066), a two component response regulator; rpoZ
(BME1297), RNA polymerase omega subunit and tran-
scriptional regulatory elements mucR (BME1364), lysR
(BMEI0513) and deoR (BME0304). Additional factors
important for survival include virB, LPS biosynthesis
genes and several metabolic functions. Differences were
observed in the survival ratios over time for several of the
mutants and may reflect differences in the timing of their
expression. For example, genes encoding cytochrome bd
oxidase function appear to be important later in infection,
while most other functions have a more dramatic effect
early in infection (Fig. 2).
Fluorescence screen of Himar 1 mutant replication in macro-phageigure 1
Fluorescence screen of Himar 1 mutant replication in 
macrophage. Preliminary screening was performed using 
J774.A1 macrophage-like cells that were infected with B. 
melitensis 16 M (panel A) or individual mutants (panels B, C, 
D) in 96-well microtiter dishes at MOI of 50, as described in 
Materials and Methods. Replication of each mutant was visu-
alized using goat anti-B. melitensis and donkey-anti-goat IgG-
Alexa Fluor 488. Images similar to those shown were cap-
tured using an Olympus IX70 inverted fluorescent micro-
scope.Page 3 of 15
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An issue raised in earlier work with regard to the identifi-
cation of virulence genes is whether reduced survival
observed in macrophages can be said to be specific to the
intracellular environment. Although such a definition is
meant to enhance focus on pathogenic mechanisms, it
has the disadvantage of categorically eliminating mutants
that may be useful either in characterizing the intracellular
environment in which Brucella persists or for vaccine
development. Mutants exhibiting obvious growth defects
in vitro were naturally eliminated during early steps of the
screening process due to poor growth. However, mutants
exhibiting modest defects were present among the group
identified. For example, purine auxotrophs appear to
grow poorly in vitro when in competition with the paren-
tal wild-type organisms (Table 2). Yet, their growth defect
in macrophages reveals an interesting and important
aspect of the environment in which the organism persists
within the cell [15]. For all of these reasons we have pro-
vided the competitive growth ratios for comparison with
macrophage and mouse splenic clearance (Table 2). Over-
all the in vitro growth ratios were smaller than those
observed in mice or in macrophages, although the latter
was not performed under competitive growth conditions
but reflected relative macrophage growth potential of
mutant and wild-type. We have assumed, but not estab-
lished with certainty, that small growth defects are exacer-
bated when the organism is exposed to stressful
conditions within the cell. Although several of the
mutants identified may be so described, reduced survival
could be claimed for mutants exhibiting the slightest
alteration of growth in vitro, and for that reason, should
not be used as sole criterion to eliminate mutants from
careful consideration.
Extrapolations based on the interruption of a single gene
within a metabolic pathway should be carefully proposed,
as illustrated by the difference in survival characteristics
reported previously [8,16] and confirmed here for inter-
ruptions in eryC and eryB in B. melitensis (Fig. 3). The
mouse splenic clearance reveals a tenfold difference in
survival characteristics of eryC and two independently
derived eryB mutants despite similar sensitivities to eryth-
ritol (Fig. 3 and data not shown) confirming previous
results evaluating B. suis and B. abortus [8,16]. Since the
metabolic utilization of erythritol should have a similar
Table 1: Himar 1 gene interruptions that attenuate survival of B. melitensis 16 M in J774.A1 macrophages assorted according to COG‡
Functional Class B. melitensis (BME) locus* Genes Identified (#) Fraction Identified (%) Novel Genes (#) Target Specificity†
Intracellular trafficking, secretion II0025, II0026, II0027, II0028, 
II0029, II0029/30 II0030, II0032, 
II0033, II0034, II0035
11 12% 3 12.8
Nucleotide transport and metabolism I0233, I0295, I0296, I1123, 
I1124, I1127, I1204, I1240, 
I1488, I1519
10 11% 5 3.5
Signal transduction I0066, I1296, I1327, I1807, 
II0011
5 5% 3 2.4
Transcription I0304/5, I0371, I0508, I0513, 
I0513/4, I0731/2, I0808, 
I1178, I1297/8, I1364, I1647/
8, II1116, II1116/7
13 14% 11 2.1
Cell wall/membrane/envelope biogenesis I0498/9, I0997, I1302, I1326, 
I1393, I1413, I1414, I1415, 
I1416, I1426, I1427, I1886, 
II0380, II0472, II0899
15 16% 7 1.9
Energy production and conversion I0972, I1749, II0428, II0429, 
II0759, II0760, II0761, II0762
8 8% 2 1.2
Amino acid transport and metabolism I0025, II0039, II0040, II0285, 4 4% 1 1.0
Replication, recombination and repair I0040, I0334, I1307, I2023, 
II0260
5 5% 4 0.5
Translation, ribosome structure and biogenesis I0983, I1057, I1775/6 3 3% 3 0.4
Function unknown I0186, I0193, I0490, I0540, 
I0603, I0732, II0045/6
7 7% 7 0.4
Posttranslational modification, protein turnover, 
chaperones
I0816, I1804,II0932 3 3% 2 0.4
Defense mechanisms I0926 1 1% 1 0.3
General function prediction I1143, I1282, I1487, I1499, 
I1867, I1894
5 5% 5 0.2
Carbohydrate transport and metabolism I2031, II1095 2 2% 1 0.2
Lipid transport and metabolism I1553 1 1% 0.1
Coenzyme transport and metabolism I0657 1 1% 1 0.1
‡ Genes assigned to COGs that are not listed were not identified.
* Numbers in bold reflect novel identification (n = 57). Those that are not bold have been identified previously using Tn5 by us and others [46]
/ Indicates intergenic insertion between two genes.
† ts or target specificity represents the ratio of insertions per COG divided by the fraction of the genome represented by that COG.Page 4 of 15
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Chr BME GENE FUNCTION Gene S v. Ra In vitro
Survival
Ratio
M∅ Survival Ratioc Mouse Survival Ratioc,d
Intracellular trafficking, secretion, and vesicular transport
I 1894 Gramicidin S biosynthesis grsT S -0.4 1.5 0.9
II 0029–30 VirB5-B6 virB5/6 S
II 0034 Type IV secretion (channel protein) virB10 S 2.5*
II 0035 Type IV secretion (ATPase) virB11 S 2.3***
Nucleotide transport and metabolism
I 0233 Phosphoribosylaminoimidazolecarboxamide formyltransfease purH S 0.4 0.9
I 0295 Phosphoribosylaminoimidazole carboxylase ATPase subunit purK S 0.3 0.9
I 1123 Phosphoribosylformylglycinamidine (FGAM) synthase purS S 0.9 2.9
I 1124 Phosphoribosylformylglycinamidine (FGAM) synthase purQ S 1.9 2.2
I 1204 Exopolyphosphatase (Ppx/GppA) ppx S 0.4 1.2
Signal transduction mechanisms
I 0066 Response regulator (two component) ompR S 0.6 1.3 1.9*
I 1327 Glutamate-ammonia-ligase adenylyltransferase (signal 
transduction)
glnE S -0.1 1.2 1.4
I 1807 Universal stress protein uspA S 0.4 0.1
Transcription
I 0304/5 Hypothetical thioesterase-transcriptional regulator deoR S -0.5 1.9
I 0371 Regulatory factor (rpoE) virF S -0.1 1.1 0.3
I 0508 Transcription elongation factor greA S 1.0 0.7 0.6
I 0513 Transcription factor lysR S 0.9
I 0513/4 Transcription factor-hypothetical protein lysR/hyp S 0.2 0.7
I 0731/2 Cold shock protein-hypothetical cytosolic protein csp/hyp S 0.2 1.1 0.9
I 0808 Transcriptional regulator (soxR) merR S 1.0 0.8
I 1178 Transcriptional regulator (soxR) merR S 0.0
I 1297/8 RNA polymerase omega subunit-hypothetical protein rpoZ/hyp S 0.2 1.3
I 1364 Transcriptional regulatory protein mucR S 0.3 2.0*** 3.0**
I 1647/8 Hyp-RegM (ATP-binding) hyp/regM S 1.0 -0.2
II 1116/7 Transcriptional activator LuxR-TetR families luxR/tetR S 0.1 1.6** 1.1
Cell wall/membrane/envelope biogenesis
I 0498/9 Cold shock protein/soluble lytic transglycosylase cspA/slt R 0.0 1.7*** 2.9
I 1302 Soluble lytic murein transglycosylase mltE R 0.6 0.7 0.4
I 1415 O-antigen export system permease protein rfbD R 0.1 1.3
I 1416 O-antigen export system ATP-binding protein rfbE R 0.3 1.9**
I 1427 UDP-N-acetylglucosamine 4,6-dehydratase capD R -0.3 1.4
II 0380 Acriflavin resistance protein A (membrane biogenesis) acrA(hlyD) S 3.4
II 0472 Membrane fusion protein (membrane biogenesis) mtrC(hlyD) S 0.9 0.3
Energy production and conversion
I 0972 Glutathione reductase gor S 0.3 0.5
I 1749 FAD-dependent glycerol phosphate dehydrogenase glpD S 0.2 0.7
Amino acid transport and metabolismPage 5 of 15
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Replication, recombination and repair
I 0334 AAA ATPase/DNA helicase/DNA damage checkpoint ruvB S 1.3 0.9
I 1307 Integrase/recombinase (phage) xerC (int) S 0.1 1.1
I 2023 ATP-dependent nuclease subunit A uvrD/rep S 0.9
II 0260 GTP-binding protein lepA S 0.9 0.1
I 1296 GTP-binding protein lepA S 1.0
Translation, ribosome structure and biogenesis
I 0983 Ribosomal large subunit pseudouridine synthase C rluA S 0.5 1.1 1.0
I 1057 Ribonuclease E/Zn metalloprotease cafA S 0.5 1.1 1.6
I 1775–6 Rnase PH-HrcA (heat shock protein repressor) rph/hrcA S -0.2 1.0 0.6
Function unknown
I 0186 Hypothetical cytosolic protein dut S 0.6 0.4
I 0193 Hypothetical protein hyp S 0.4 2.4 1.5
I 0490 Hypothetical cytosolic protein hycp S 0.6 0.6
I 0540 Hypothetical protein hyp S 0.0 0.6
I 0603 Hypothetical protein hyp S -0.1 1.1
I 0732 Hypothetical cytosolic protein hycp S 1.4
II 0045–6 Hypothetical protein-Hypothetical protein hyp/hyp S
Posttranslational modification, protein turnover and chaperones
I 0816 ATP-dependent clp protease ATP-binding subunit clpA S 1.0 0.8 1.5
II 0932 Glutaredoxin nrdH S 1.1 -0.3
Defense mechanisms
I 0926 Multidrug resistance locus emrA 2.2
General function prediction
I 1143 Metal-dependent hydrolase (β-lactamase) mbl S -0.1 0.9
I 1282 Glycine cleavage T protein (aminomethyltransferase) gcvT S 1.2 0.4
I 1487 Colicin V production protein colV S 1.2 0.5 0.8
I 1499 Pirin (cupin) pirA S -0.1 1.3 1.7
I 1867 Florfenicol resistance protein nifB/elp3 S 0.4 0.5
Carbohydrate transport and metabolism
I 2031 Phosphocarrier protein HPr ptsH S -0.3 0.9 0.4
II 1095 L-fuculose phosphate aldolase sbgE S 0.7 2.2*
Lipid transport and metabolism
Coenzyme transport and metabolism
I 0657 Outer membrane receptor (TonB-dependent transport) btuB S 0.2 0.6
a S v. R denotes smooth versus rough colony morphology
b In vitro growth: 1:1 mixtures of 16 M and select mutants used to inoculate culture to evaluate growth defects of the mutant. The output ratios are 
corrected for variance from the input ratios (approximately 1.0) and presented as a log10 value, also refrerred to as Δlog10. Macrophage survival is 
presented as a log10 of the ratio of recovery 16 M to mutant which may also be presented as Δlog10.
c Statistical analysis of macrophage and mouse splenic clearance revealed significant differences among means using 1-way ANOVA, Dunn's multiple 
comparisons using a non-attenuated mutant revealed statistically valid differences with p-values of 0.05 (*), 0.01 (**) and 0.001 (***).
d Mouse splenic clearance: 1:1 mixtures of 16 M and select mutants were used to inoculate mice i.p. to evaluate degree of in vivo attenuation of 
survival at one week.
/ Indicates intergenic insertion between two genes.
Table 2: Summary of survival characteristics of novel attenuated mutants (Continued)Page 6 of 15
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may be explained by differences in the buildup of toxic
metabolic intermediates.
Genes that were not identified using Himar transposable 
element insertion mutagenesis
Published reports suggest the potential identification of
genomic islands (GI) that may explain the gain or loss of
virulence function in Brucella [17]. Examination of the
mutants identified in this work revealed an insertion in
only one of the 141 loci representing the 9 GI described.
This low level agreement is quite striking and is not attrib-
utable to differences in AT content of the GIs and the Bru-
cella genome. Interestingly, despite the near saturated
mutagenesis of the operons encoding the T4SS and the
purine metabolic pathway, there were no hits in any gene
within the flagellar locus (BMEII1078–1089), which is
thought to potentially encode a type 3 secretion system
(T3SS). However, interruption was identified in at least
one neighboring locus (BMEII1095).
Discussion
The genomes of Brucella species are replete with genes
encoding metabolic functions but contain few that
encode classically defined virulence genes. Previous stud-
ies have reported the significance of metabolic functions
to survival but have not claimed saturation mutagenesis
of the Brucella genome. This leaves room for the identifi-
cation of additional functions [5-7,12]. The aim of this
study was to identify additional functions required for vir-
ulence using a transposon with different target specificity
(ts) and elevated transposition frequency. The reported
Survival characteristics of novel and previously identified mutants validated in the mouse splenic clearance model of infectionFigure 2
Survival characteristics of novel and previously identified mutants validated in the mouse splenic clearance 
model of infection. To confirm attenuated virulence several of the mutants were evaluated for survival in the mouse splenic 
clearance model using a 1:1 mixture of parental wild-type (B. melitensis 16 M) and mutant to inoculate mice (n = 10 per group) 
with an overall dose of 5 × 106 cfu. At one (white bars) and four weeks (black bars) post inoculation spleens were excised from 
the mice, and recovery of the B. melitensis 16 M and the mutant were determined as described in the Materials and Methods. 
Recovery of Brucella is presented as a Survival Ratio (CFU 16 M/CFU mutant) corrected for variation in the input ratio in the 
inoculum calculated the same way.Page 7 of 15
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genes that were not previously identified using a random
approach. The genes identified as important for intracel-
lular survival in this work have been arranged according to
their COGs (Table 1). Reviews of several databases have
revealed discrepancies in overall COG assignment, and in
the analysis shown, the genes are distributed according to
COG assignments in the Integrated Microbial Genomes
database (DOE).
Analysis reveals an elevated propensity for interruption of
genes involved in intracellular trafficking (U), nucleotide
metabolism (F), transcription (K), membrane biogenesis
(M) and energy production and conversion (C). This fre-
quency is determined by calculating the number of genes
assigned to each COG divided by the total number of
genes identified and ignores the overall frequency with
which a particular gene or group of genes was identified in
the screen. In an alternative calculation, the total number
of independent hits within a gene, identified by unique
insertion point via DNA sequence analysis, was also calcu-
lated as a fraction of the total number of transposon inser-
tions. When this number is divided by the fraction of the
genome represented by a COG number, results reflect the
relative specificity with which a particular COG is identi-
fied (referred to here as target specificity (ts)). For exam-
ple, a target specificity of 1.0 indicates that the frequency
of Himar transposable element 1 insertion in a particular
COG is identical to the frequency genes of that COG
appear in the genome. Values of ts less than 1.0 suggest
Himar interruption of the erythritol locus has varying effect on virulenceFigu e 3
Himar interruption of the erythritol locus has varying effect on virulence. The virulence of mutants interrupted in 
different genes of the erythritol locus were evaluated in the mouse splenic clearance model using mixtures (approximately 1:1) 
of B. melitensis 16 M and individual mutants containing interruptions in either eryB or eryC as indicated. Recovery of the parental 
wild-type and mutant were determined one week after infection by plating spleen homogenate on TSA with and without kan-
amycin as described in Materials and Methods. The ratio of wild-type to mutant recovered is corrected for variation in the 
input ratio and the final value is expressed as a ratio of 16 M to mutant recovered as described in Materials and Methods. The 
values shown reflect the ratios recovered plotted on a log scale. Differences in the average values were evaluated for signifi-
cance via one-way ANOVA with Kruskal-Wallis test followed by Dunn's multiple comparisons between all groups p-value 
<0.0045 (**).Page 8 of 15
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importance for intracellular survival. Target specificity val-
ues much greater than 1.0 are consistent with enhanced
identification or importance for intracellular survival.
Using this approach, the COG with the highest value (≥
13.3) encoded functions associated with intracellular traf-
ficking, secretion and vesicular transport. Most notable in
this group are the genes encoding the type IV secretion sys-
tem for which 47 separate insertions were identified in 10
of 11 virB genes in this study.
The next most frequent group identified included the
genes encoding nucleotide transport and metabolism
functions (ts ≥ 3.5). This group of mutants has also been
previously described, and the results here confirm the
importance of this biosynthetic pathway with 18 separate
insertions in genes encoding nine distinct enzymatic func-
tions that attenuate survival [15]. The failure of Himar
transposable element 1 mutagenesis to identify a single
locus involved in pyrimidine biosynthesis may suggest
that saturation has not been achieved or that transposon
insertion site specificity may be responsible. However,
analysis of the overall AT content of these loci does not
support the latter argument. Pyrimidine requiring auxo-
trophs may have been eliminated from consideration,
along with many other mutations, as a result of a moder-
ate reduction in survival, i.e., tenfold or less. The poor
competitive growth of purine mutants in vitro appears to
explain their poor growth in macrophage and indicates a
low level of free nucleotides within the intracellular
milieu. Differences in relative survival rates of pyrimidine
and purine mutants cannot be explained.
In contrast with the elevated ts value for nucleotide bio-
synthesis, the values for amino acid and carbohydrate
metabolism are low, ≤ 0.97 and 0.15, respectively.
Although the value for amino acid biosynthesis appears
equivalent to the distribution in the genome overall, at
1.0, the number is greatly reduced (ts = 0.10), if insertions
in glutamate synthase genes, gltA and gltB, representing 21
out of 23 mutants identified, are excluded. This suggests
that amino acid metabolism has a limited effect on overall
survival. Previous studies have reflected on the potential
for poor nutritional content of the Brucella-containing
vacuole (BCV) based on the interruption of several impor-
tant biosynthetic pathways [7]. Although the results con-
firm the importance of purine nucleotide metabolism for
survival, the paucity of interruptions in genes concerned
with amino acid metabolism was unexpected. The poor
survival of Brucella gltBD mutants is consistent with the
concept of a Brucella containing vacuole that is reduced in
nutritional content [5-7], but the role of glutamate syn-
thase in nitrogen metabolism may be even more critical.
The identification of at least one peptide transport system
(BMEII0285) among many located on genomic islands
may preclude the need to synthesize amino acids explain-
ing the poor recovery of mutants defective in amino acid
biosynthesis [15,17]. The limited number of interruptions
within the genomic islands (1 out of 141 genetic loci)
may be explained by redundancies in transport functions.
However, caution must be used in these early interpreta-
tions, since gltBD has also been shown to alter the osmotic
sensitivity of bacteria that could play a crucial role during
intracellular survival [18]. Evidence from closely related
Rhizobial species also indicates the ability of gltBD
mutants to colonize root nodules by these mutants
despite an inability to fix nitrogen, and in this case, it has
also been rationalized that the plants provide nitrogen in
the form of amino acids [19].
Additional activities associated with amino acid metabo-
lism include two proteins that regulate glutamine synthe-
sis associated with nitrogen metabolism; glnD, the
primary sensor of nitrogen status, and glnE, a protein that
regulates glutamine synthase activity through covalent
adenylation [20]. Clearly the assimilation of nitrogen is
important to the survival of the organism and glutamate
synthase appears to be a critical control point for survival.
Among the mutants attenuated for virulence, a large
number were interrupted in genes required for lipopoly-
saccharide biosynthesis (ts ≥ 1.9). All of the genes identi-
fied (n = 15) have a direct role in the biosynthesis and
assembly of lipopolysaccharide or the cell wall to which
the LPS is attached. Nearly half of these contained inter-
ruptions within the previously described O-antigen bio-
synthetic locus (BMEI1390–1427) [21]. Several others
were associated with cell wall metabolism that also caused
a rough phenotype; this would explain reduced survival
relative to parental strain. An additional locus involved in
O-antigen expression also represents a basic metabolic
function (BMEII0899) encoding phosphomannomutase
[22]. Yet, a second pmm identified in the genome
(BMEI1396) and within the main O-antigen biosynthetic
locus shares up to 55% identity with BMEII0899 but fails
to function in the place of BMEII0899 indicating either
regulation of expression only under specific conditions or
divergence of function.
Two other novel mutants affecting O-antigen production
interrupt genes encoding soluble lytic murein transglyco-
sylases (BMEI1302). Although it is interesting to speculate
concerning the potential role in enhancing bacterial viru-
lence based on similarities with plant pathogens [23], the
rough phenotype of these mutants alone may be sufficient
to account for their attenuated virulence. Of the remain-
ing 50 novel mutants, all appear to make full-length LPS
based on agglutination tests [24]; however, the effect of
these various mutations on the production of otherPage 9 of 15
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proteins, remains to be determined.
Defense mechanisms (V) and energy production and con-
version (C) genes are grouped together in this discussion
based on the demonstrated requirement for genes of the
latter group, most notably the requirement for the previ-
ously identified alternative terminal ubiquinol oxidase
complex, cydDCBA (BMEII0759–62) in resistance to oxi-
dative stress [25]. Novel identifications include the oxi-
dase/reductase enzymes glutaredoxin (BMEII0932) and
glutathione reductase (BMEI0972) that, in addition to
relieving stress, may prove invaluable in the synthesis of
ribonucleotides including ATP and underscore the impor-
tance of purine metabolism [26]. Also among energy pro-
duction and conversion (C) functions, we have identified
glycerol-3-phosphate dehydrogenase (BMEI1749) and
genes encoding erythritol utilization functions
(BMEII0428 and 429).
Although mutation in the erythritol pathway has been
previously described, additional discussion is warranted
[8]. In recent reports, interruptions of both genes in B. suis
and B. abortus were described as attenuating survival inde-
pendently of erythritol utilization consistent with the con-
cept that toxic intermediates are responsible for reduced
survival [8,15]. Experiments reported here revealed a
more severe attenuation of eryC::Himar mutants when a
competitive infection model was employed (Fig. 3 and
Table 2). The observation that eryC::Himar attenuates sur-
vival more drastically than eryB::Himar mutation suggests
the toxic nature of the product of D-erythrulose 4-phos-
phate dehydrogenase (EryC), and the observation that
erythritol tolerance resulting from reduced erythritol
uptake improves survival is consistent with this interpre-
tation [8]. Perhaps most importantly, it is prudent to
stress that these results suggest that erythritol is not an
essential carbon source in the systems employed; other-
wise, mutation in either gene would be expected to pre-
vent bacterial growth and limit virulence. Furthermore,
similar situations may exist in other operons indicating
the need to carefully examine defects in multiple func-
tions before concluding that the entire pathway is essen-
tial for survival.
A single defense mechanism (V) was identified, the
ortholog of the multidrug resistance locus emrA
(BMEI0926) capable of preventing the buildup of toxic
by-products. The linkage between the reduction of the oxi-
dation potential within the bacterium and energy effi-
ciency are both presumably critical contributions to
survival. Several additional functions were identified that
are important in preserving DNA fidelity and the effi-
ciency of gene expression under stressful conditions that
may otherwise lead to DNA damage.
Genes associated with translation, ribosome structure and
biogenesis (J) include ribosomal large subunit pseudouri-
dine synthase C (BMEI0983) and ribonuclease E/Zn met-
alloprotease (BMEI1057). Both may control organism
survival via their roles in RNA metabolism [27,28]. The
interruption between Rnase PH and HrcA (heat shock
protein repressor) (BMEI1775–6) may affect tRNA
processing, the addition of polyA tails to mRNA regula-
tion of expression from heat shock loci depending on
polarity [29-32].
Among genes encoding functions associated with post-
translational modification, protein turnover and chaper-
ones (O), was the ATP-dependent clp protease ATP-
binding subunit clp required to relieve stress, reportedly
more important for growth of mice than in macrophage
[33,34]. Only a single gene associated with coenzyme
transport and metabolism (H) was identified in this
screen, the TonB-dependent metal chelator (BMEI0657)
[35]. Several genes were identified within the general
function prediction group (R); the glycine cleavage T pro-
tein (aminomethyltransferase) is part of the previously
described gcv operon reportedly required late in infection
[12]. The metal-dependent hydrolase (β-lactamase)
(BMEI1143) has been shown to function as possible AHL-
lactonase [36]; Pirin (BMEI1499) induced in cyanobacte-
ria under conditions of stress appears to function in the
transcription of other genes [37]; and florfenicol resist-
ance protein (BMEI1867) is frequently identified with
multi-drug resistant bacteria in cattle [38,39].
Of special interest in this work was the identification of a
number of novel genetic loci that regulate gene expression
essential to intracellular survival. This group includes
both functions associated with signal transduction (ts =
2.4) and transcriptional control (ts = 2.1). Of these mucR,
tetR, luxR and hydG stand out as most critical for survival.
The importance of LuxR (BMEII1116) and HydG
(BMEII0011) in survival has been previously evaluated,
but the other regulators (MucR, TetR, OmpR and VirF)
have not. TetR reportedly had no effect on survival in a
systematic approach study [40], and the fact that the trans-
poson insertion identified was actually intergenic suggests
a possible influence on luxR expression (BMEII1116)
rather than from tetR (BMEII1117). TetR regulators have
been observed in a number of bacteria and are frequently
involved in the regulation of quorum sensing loci [40,41].
MucR regulators are frequently observed among the α-
proteobacteria in which they regulate expression of
exopolysaccharide production [42]. Preliminary results
reveal that this mutant makes normal levels of LPS (O-
antigen) and VirB gene products. The basis for its reduced
survival relative to parental strain is currently under inves-
tigation. OmpR represents a two-component response
system similar to the previously described BvrR/BvrS sys-Page 10 of 15
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vation in regions 2 and 4 involved in -10 and -35 region
recognition and binding [44], and rpoZ encodes an RNA
polymerase omega subunit important for assembly and
function of RNA polymerase. However, the proximity of
this locus to the BMEI1296, which was also identified in
this screen and recently described in more detail, suggests
that more careful analysis of nonpolar deletions may be
required to confirm the role of the rpoZ locus in virulence
[45]. The cold shock protein encoded by cspA may also be
a critical factor, although the intergenic nature of this
insertion and others suggests a possible role for small
RNAs in survival and virulence and such analysis is in
progress. GreA is required to prevent pausing transcrip-
tion elongation at specific sites and may reduce the sur-
vival of the organism under stringent growth conditions
as revealed during competitive in vitro growth.
Conclusion
Overall, more than half of the genes identified in this
study using a random mutagenesis approach have not
been identified with virulence of Brucella. However, in
many cases the genes identified are associated with well-
known groups of functions affecting survival of Brucella.
Among these are the genes associated with the synthesis of
the T4SS, LPS biosynthesis and purine metabolism. The
failure to previously identify these mutants may either be
attributable to the difference in insertion site specificity of
the mariner transposon relative to Tn5 or the potential
that the Tn5 screens performed to date have not achieved
genome saturation [15,46]. In defense of previous work,
the stated goal was the identification of genes required for
virulence/survival and there was no claim that saturated
mutagenesis was achieved. Similarly, the work reported
here still cannot claim with certainty that saturation muta-
genesis has been achieved. In addition, the potential for
both false negative or false positive results cannot be elim-
inated. Therefore, it is still important to verify the contri-
bution of each gene identified by performing both
deletion mutagenesis and complementation of the genes
in question. This work is currently in progress focusing on
the novel identifications reported. Although a handful of
the genes identified were shown to cause in vitro growth
defects in rich media, only a few of these exhibited growth
defects as low as that observed in macrophages or in the
mouse splenic clearance model. Interestingly, a number
of mutants exhibiting reduced in vitro growth have been
previously described as attenuated for intracellular sur-
vival [6,15]. Again, it should be noted that although those
functions were identified as important for intracellular
survival, they were not described as specific to intracellu-
lar survival. These results emphasize the need to examine
these effects on a gene-by-gene basis and argue against
broad generalizations concerning reduced fitness vs.
pathogenesis. However, the use of such defects in the con-
struction of vaccine strains remains a viable option, since
such organisms may be easily prepared using supple-
mented media while retaining in vivo growth defect.
Methods
Bacterial Strains and Media
Brucella melitensis 16 M (American Type Culture Collec-
tion 23444) re-isolated from an aborted goat fetus and all
Himar1 transposable element-derived mutants were rou-
tinely grown in tryptic soy broth (TSB) or tryptic soy agar
(TSA) with/without kanamycin at 37°C. Bacteria from liq-
uid culture or resuspended plate cultures are quantified
spectrophotometrically using a standardized growth
curve. Accurate determinations of culture density are
determined by serial dilution and plating portions on TSA
plates. For conjugation, Escherichia coli β2155 donor
strain bearing the plasmid pSC189 and containing a
Himar1 transposable element was cultivated in TSA con-
taining 50 μg/ml DAP (diaminopamelic acid) [47]. Both
parental bacterial strains and their mutated derivatives
were maintained as frozen stocks following the addition
of glycerol to a final concentration of 25%(v/v). Antibiot-
ics were used to supplement the media at final concentra-
tions of 100 μg/ml (kanamycin) and 40 μg/ml
(gentamicin).
Conjugation and mutagenesis
B. melitensis 16 M was grown on solid media up to 72
hours as described above. E. coli β2155 with or without
pSC189 was grown on TSA supplemented with DAP (50
μg/ml) and kanamycin for 24 hours. Donor and recipient
bacteria on each of the plates were harvested in 5 ml of
peptone-saline [1% (w/v) Bacto-peptone™ and 0.5% (w/
v) NaCl] containing DAP. Equal volumes (100 μl) of bac-
terial suspensions were mixed together to provide a donor
to recipient ratio of approximately 1:100. The suspension
was plated on nitrocellulose filters placed on the surface
of TSA plates supplemented with DAP (50 μg/ml) and
incubated for no more than two hours at 37°C. Serial
dilutions of the conjugation mixtures were prepared in
peptone saline and plated onto TSA plates supplemented
with kanamycin (100 μg/ml) to evaluate Brucella transfor-
mation efficiency. Using these conditions, growth of the
donor E. coli strain β2155 strain was repressed by the
absence of DAP, and no exconjugants were obtained in
mixtures of B. melitensis 16 M with E. coli β2155 lacking
pSC189. The remaining bacterial conjugation mixture was
stored in peptone saline at 4°C. The transconjugants were
plated on TSA containing 100 μg/ml kanamycin and the
isolated colonies were transferred to 96-well plates con-
taining TSB supplemented with kanamycin. The bank
consists of 18,708 mutants in 195 microplates and repre-
sents sixfold coverage of the genome (i.e., averages 6 inser-
tions per gene) with greater than 99% assurance of
covering the entire genome [48].Page 11 of 15
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The method used has been described extensively else-
where [49]. Briefly, Brucella were grown in TSB or TSB with
appropriate antibiotic for approximately 24 hours.
J774.A1 macrophage at low passage were used to seed the
wells of a 24 well plate at 2.5 × 105 per well in 0.5 ml
DMEM. Bacterial cultures were washed and diluted 5-fold
with PBS prior to addition to each of four wells for each
strain at a final MOI (multiplicity of infection) of 50
determined as described above. The plates were centri-
fuged at 200 × g for 5 min at room temperature and then
incubated at 37°C for 20 minutes. The infected cell mon-
olayers were washed with PBS (or peptone saline) three
times, overlaid with 0.5 ml of DMEM containing 50 μg/
ml gentamicin and incubated at 37°C for various times.
Following these incubations the media was replaced with
0.5 ml of solution containing 0.5% (v/v) Tween-20 to lyse
the macrophage monolayer. The cell lysate was pipetted
vigorously to ensure cell lysis and serial dilutions were
prepared in PBS and portions plated on TSA supple-
mented with antibiotic as necessary to evaluate bacterial
survival. The results are presented as the difference in rep-
lication for wild-type and mutant strains using the follow-
ing formula: log10 [(CFU 16 M at 48 h/CFU 16 M at 1 h)]
minus log10 [(CFU mutant at 48 h/CFU mutant at 1 h)].
The values presented represent the means of at least three
separate experiments.
Identification of attenuated mutants
Based on the calculated transformation efficiency, conju-
gation mixtures were diluted and plated onto TSA supple-
mented with kanamycin. Single colonies were visible
within 72 hours and transferred from the TSA plates to
individual wells of 96-well microtiter dishes containing
TSB supplemented with kanamycin and incubated for 48
hours at 37°C. These dishes were used to prepare dupli-
cate dishes for storage at -80°C after adjusting the cell sus-
pensions to 20% (v/v) with sterile glycerol and were also
used to prepare fresh culture for macrophage infection fol-
lowing resuspension (1:20 dilution in 100 μl) in fresh TSB
supplemented with kanamycin and incubation at 37°C
for 24 hours. Murine macrophage-like J774.A1 cells were
seeded in 96-well microtiter dishes at 5×104 cells/well and
incubated for 18 hours at 37°C in atmosphere containing
5% (v/v) CO2. Infections were performed with the addi-
tion of 10 μl of the 24-hour cultures of bacteria at a final
multiplicity of infection (MOI) of approximately 50. Bac-
teria were pelleted onto the cell monolayers by centrifuga-
tion for 5 minutes at 200 × g to synchronize uptake.
Cultures were incubated at 37°C for 20 minutes prior to
removal of extracellular bacteria by washing with peptone
saline. Incubation was continued at 37°C up to 48 hours
following the addition of 200 μl complete DMEM supple-
mented with 40 μg/ml gentamicin.
Following incubation, the media was removed and the
monolayer fixed with 200 μl of 3.7% (v/v) formaldehyde
at room temperature for 30 minutes. The fixed monolay-
ers were washed three times with PBS [10 mM sodium
phosphate and 150 mM NaCl, pH 7.4], followed by incu-
bation with 50 μl of goat-anti-B. melitensis 16Mserum
diluted 1:500 in PBS-TT [PBS with 0.05% (w/v) Tween-20
and 0.05% (v/v) Triton X-100] prior to incubation for 1
hour at room temperature. The primary antibody was
removed and the plates washed three times with 200 μl
PBS-T (PBS with 0.05% (v/v) Tween 20). Fifty μl of don-
key-anti-goat IgG-Alexa Fluor 488 diluted 1:500 in PBS-TT
was then added to each well and incubation continued for
1 hour at room temperature in the dark. The plates were
washed again three times with PBS-T followed by PBS and
evaluated via fluorescence microscopy (Olympus IX70) as
described previously [49]. In contrast to infection by B.
melitensis 16 M that grows well and exhibits numerous
cells full of bacteria, multiplication of attenuated mutants
is greatly reduced in number and/or present in only a few
macrophages.
Isolation of genomic DNA and identification of interrupted 
loci
Extraction, preparation and subsequent DNA sequence
analysis were all performed as previously described with
the following specific changes warranted by the use of
mariner transposon Himar 1 [12]. First, genomic DNA
from attenuated mutants was digested with HaeIII. Ampli-
fication of the interrupted loci utilized mariner-specific
forward 5'-CAACACTCAACCCTATCTCG-3' and reverse
primers 5'-CACTCAACCCTATCTCGGTC-3' under the fol-
lowing conditions: 95°C 4 min, 30X (95°C 30 sec, 57°C
30 sec, 72°C 90 sec), 72°C 7 min. PCR products were
purified from agrose gel using the QIAquick Gel Purifica-
tion Kit (Qiagen, Valencia, CA). Sequencing was per-
formed using the primer 5'-
CACTCAACCCTATCTCGGTC-3' at the Gene Technolo-
gies Laboratory (GTL, Institute of Developmental and
Molecular Biology, BSBW 437 Texas A&M University, Col-
lege Station, TX 77843-3155).
The sequences were blasted against the B. melitensis
genome database [50] to identify and confirm the identity
of the disrupted genes. Gene function predictions and
assignment to clusters of orthologous genes (GOGs) was
performed using the Integrated Microbial Genomes data-
base available through the Department of Energy (DOE)
web page [51]. Additional analysis, including identifica-
tion of the site of transposon insertion were performed
using MacVector™ (Accelrys, Inc.) using the sequence for
B. melitensis 16 M generated by DelVecchio et al [52].
Locus tags for the large chromosome BMEI (1–2060) and
for the small chromosome BMEII (1–1138).Page 12 of 15
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Plasmid pKD4 was used as template to provide the probe
used for Southern blotting, which was prepared by PCR
amplification of the neomycin phosphotransferase gene
(nptII gene) using forward 5'-CGGGATCCCGCACGTCTT-
GAGCGATTGTGTAGG-3') and reverse primers 5"-
CGGGATCCCGGGACAACAAGCCAGGGATGTAAC-3'
[53]. Cycling conditions were 95°C for 5 minutes, 30
cycles of 95°C 30 seconds/62°C 30 seconds, 72°C 1.5
minutes and a final extension at 72°C for 10 minutes.
PCR products were purified using the QIAquick Gel
Extraction Kit (Qiagen, Valencia, CA). These PCR products
were labeled with fluoroscein, as described by the manu-
facturer (NEN Life Science), and the concentration of the
labeled probe was used at a range of 10–20 ng/ml. Restric-
tion digestion, agarose gel electrophoresis of restriction
digested genomic DNA, Southern blotting, probe prepara-
tion, hybridization and film exposure were all as previ-
ously described [49]. Two enzymes (HindIII and NcoI)
were used to evaluate the transposon insertions in the
mutant genomes. There are no HindIII sites and one NcoI
site within the transposon, resulting in a single and two
nptII fragments, respectively.
Survival in the mouse splenic clearance model
Survival of B. melitensis 16 M and attenuated mutants in
mice was performed as previously described [12]. Briefly
a mixture (1:1) of parental strain and mutant was resus-
pended in PBS and inoculated into the peritoneal cavity of
mice. Spleens were harvested as early as one week, and no
later than five weeks, post inoculation and homogenized
in PBS. Serial dilutions were prepared and the bacterial
recovery determined by plating on TSA and TSA supple-
mented with kanamycin (TSAK). Wild-type and mutant
will grow on TSA, while only the mutant exhibits growth
on TSAK. The results are presented as the ratio of (CFUwt/
CFUmutant) recovered to the ratio inoculated (CFUwt/CFU-
mutant) or the difference in log10 of these values and reflects
the average of at least three separate assays.
Competitive in vitro growth
In vitro and in vivo competitive growth and auxonography
were performed; the competitive growth indices were cal-
culated as described previously and reflect the median of
at least three separate assays [12]. Competitive growth
ratios are reported (as described above) for survival in the
mouse splenic clearance model and are representative of
at least three separate experiments.
Statistical analysis
Primary screening in macrophage was performed twice for
all 18,708 mutants, and only those exhibiting reduced
survival in duplicate wells as described in the Results were
chosen for additional analysis. Gentamicin protection
assay was then performed for all 443 mutants, and those
exhibiting tenfold or greater reduction in survival at 48
hours in this assay relative to 16 M were selected for fur-
ther analysis. Additional gentamicin protection assays
and survival in the mouse splenic clearance model were
performed for selected mutants, and the survival ratios
calculated as described above were analyzed using
ANOVA via Prism™ with either Kruskal-Wallis or Frei-
dman tests. Groups with statistically valid differences in
their means were further evaluated using Dunn's multiple
comparison post-test to establish differences from viru-
lent organism (Graphpad, Inc.).
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